Alkaptonuria

被引:76
作者
Mistry, Jemma B. [1 ]
Bukhari, Marwan [2 ]
Taylor, Adam M. [1 ]
机构
[1] Lancaster Med Sch, Fac Hlth & Med, Lancaster, England
[2] Univ Hosp Morecambe Bay NHS Fdn Trust, Royal Lancaster Infirm, Lancaster, England
关键词
alkaptonuria; ochronosis; ochronotic arthropathy; osteoarthritis; homogentisic acid; homogentisate 1,2 dioxygenase;
D O I
10.4161/rdis.27475
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Alkaptonuria (AKU) is a rare disorder of autosomal recessive inheritance. It is caused by a mutation in a gene that results in the accumulation of homogentisic acid (HGA). Characteristically, the excess HGA means sufferers pass dark urine, which upon standing turns black. This is a feature present from birth. Over time patients develop other manifestations of AKU, due to deposition of HGA in collagenous tissues, namely ochronosis and ochronotic osteoarthropathy. Although this condition does not reduce life expectancy, it significantly affects quality of life. The natural history of this condition is becoming better understood, despite gaps in knowledge. Clinical assessment of the condition has also improved along with the development of a potentially diseasemodifying therapy. Furthermore, recent developments in AKU research have led to new understanding of the disease, and further study of the AKU arthropathy has the potential to influence therapy in the management of osteoarthritis.
引用
收藏
页数:7
相关论文
共 67 条
[1]   Hereditary disorders mimicking and/or causing premature osteoarthritis [J].
Bálint, G ;
Szebenyi, B .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2000, 14 (02) :219-250
[2]  
BLIVAISS BB, 1966, ARCH PATHOL, V82, P45
[3]  
BOEDEKER C, 1861, ANN CHEM PHARM, V117, P98
[4]  
Boedeker C.W., 1859, Z RATION MED, V7, P130
[5]   SCREENING FOR INHERITED METABOLIC DISEASE IN WALES USING URINE-IMPREGNATED FILTER PAPER [J].
BRADLEY, DM .
ARCHIVES OF DISEASE IN CHILDHOOD, 1975, 50 (04) :264-268
[6]   Subchondral bone as a key target for osteoarthritis treatment [J].
Castaneda, Santos ;
Roman-Blas, Jorge A. ;
Largo, Raquel ;
Herrero-Beaumont, Gabriel .
BIOCHEMICAL PHARMACOLOGY, 2012, 83 (03) :315-323
[7]   The success of dietary protein restriction in alkaptonuria patients is age-dependent [J].
de Haas, V ;
Weber, ECC ;
de Klerk, JBC ;
Bakker, HD ;
Smit, GPA ;
Huijbers, WAR ;
Duran, M ;
Poll-The, BT .
JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (08) :791-798
[8]   Quantitation of homogentisic acid in normal human plasma [J].
Deutsch, JC ;
SanthoshKumar, CR .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 677 (01) :147-151
[9]   Outcome of tyrosinaemia type III [J].
Ellaway, CJ ;
Holme, E ;
Standing, S ;
Preece, MA ;
Green, A ;
Ploechl, E ;
Ugarte, M ;
Trefz, FK ;
Leonard, JV .
JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 (08) :824-832
[10]   The molecular basis of alkaptonuria [J].
FernandezCanon, JM ;
Granadino, B ;
deBernabe, DBV ;
Renedo, M ;
FernandezRuiz, E ;
Penalva, MA ;
deCordoba, SR .
NATURE GENETICS, 1996, 14 (01) :19-24